PT  - JOURNAL ARTICLE
AU  - Masayoshi Zaitsu
AU  - Yoshihiko Hosokawa
AU  - Sumiyo Okawa
AU  - Ai Hori
AU  - Gen Kobashi
AU  - Takahiro Tabuchi
TI  - Use of heated tobacco products may be associated with hypertensive disorders of pregnancy and low birth weight in Japan: An analysis of the JACSIS study
AID  - 10.1101/2021.04.12.21255292
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.12.21255292
4099  - http://medrxiv.org/content/early/2021/04/17/2021.04.12.21255292.short
4100  - http://medrxiv.org/content/early/2021/04/17/2021.04.12.21255292.full
AB  - Background Little is known about heated tobacco product (HTP) use in pregnant women and associated maternal and neonatal risks for hypertensive disorders of pregnancy (HDP) and low birth weight (LBW). Thus, this study aimed to assess the status of HTP use among pregnant women in Japan and explore the risk of HDP and LBW associated with HTP use.Methods Using data from the Japan “COVID-19 and Society” Internet Survey (JACSIS) study, a web-based nationwide survey, we investigated 558 post-delivery and 365 currently pregnant women in October 2020. We assessed the prevalence of ever HTP smokers (defined as ever experiencing HTP use) in post-delivery and currently pregnant women. Among post-delivery women, we collected the information regarding HDP and LBW based on their Maternal and Child Health Handbooks (maternal and newborn records). In the multivariable regression analysis, we estimated the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of ever HTP smokers for HDP and LBW compared with those of never HTP smokers using logistic regression. A stratified analysis with respect to combustible cigarette smoking (never/ever) was also performed.Results The prevalence of ever HTP use were 11.7% and 12.6% in post-delivery and currently pregnant women, respectively. Among post-delivery women, ever HTP smokers had higher HDP incidence (13.8% vs. 6.5%, P=0.03), with an OR of 2.78 (95% CI 0.84–9.15) and higher LBW incidence (18.5% versus 8.9%, P=0.02), with an elevated OR of 2.08 (95% CI 0.80–5.39). A similar tendency was observed among never and ever combustible cigarette smokers.Conclusion In Japan, the incidence of HTP use has exceeded 10% among pregnant women, and HTP smoking may be associated with increased maternal and neonatal risks. School-based tobacco prevention and cessation programs should be conducted regardless of product types to prevent life-threatening perinatal complications and deaths.What this paper addsLittle is known about heated tobacco product (HTP) use and associated perinatal risks among pregnant women.In Japan, the prevalence of ever HTP use exceeded 10% among pregnant women.HTP use approximately doubled perinatal risk of hypertensive disorders of pregnancy and low birth weight.When stratified by cigarette smoking status, a similar tendency was observed among never and ever cigarette smokers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partly supported by Health, Labour and Welfare Sciences Research Grants (20FA1005) and the Japan Society for the Promotion of Science (JSPS KAKENHI JP18K17351).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the Osaka International Cancer Institute approved the study (Protocol Number 20084)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on reasonable request. However, restrictions apply to the availability of these data due to personal identification; research data are not shared. If any person wishes to verify our data, they are most welcome to contact the corresponding author.